Showing 21 - 40 results of 268 for search '"organ transplantation"', query time: 0.09s Refine Results
  1. 21

    Elevated Incidence of Fractures in Solid-Organ Transplant Recipients on Glucocorticoid-Sparing Immunosuppressive Regimens by B. J. Edwards, A. Desai, J. Tsai, H. Du, G. R. Edwards, A. D. Bunta, A. Hahr, M. Abecassis, S. Sprague

    Published 2011-01-01
    “…This study was conducted to assess the occurrence of fractures in solid-organ transplant recipients. Methods. Medical record review and surveys were performed. …”
    Get full text
    Article
  2. 22
  3. 23
  4. 24
  5. 25

    Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge by Bairu Shen, Zi Guo, Peng Huang, Minghua Tan, Xiaoshen Zhang, Siyao Lin, Changshan Song, Jiaqing Wang, Minqian Huang

    Published 2022-01-01
    “…Immunotherapy should be carefully selected for patients with combined malignancies after organ transplantation. Antivascular targeted therapy is one of the options worth considering; the risk of side effects of drug therapy is something that needs to be closely monitored when combined with immunotherapy.…”
    Get full text
    Article
  6. 26
  7. 27

    The Surgical Clinics of North America, vol. 66, no. 3 : organ transplantation /

    Published 1986
    “…organ transplantation /…”
    View in OPAC
    Book
  8. 28
  9. 29
  10. 30
  11. 31
  12. 32
  13. 33

    The Role of The Cytomegalovirus Antigenemia Assay in the Detection and Prevention of Cytomegalovirus Syndrome and Disease in Solid Organ Transplant Recipients: A Review of the British Columbia Experience by Erica D Greanya, Nilufar Partovi, Eric M Yoshida, R Jean Shapiro, Robert D Levy, Chris H Sherlock, Gwen M Stephens

    Published 2005-01-01
    “…BACKGROUND: The pp65 cytomegalovirus (CMV) antigenemia assay has been used as a means of guiding the pre-emptive therapy of CMV disease in solid organ transplant (SOT) recipients. Recently, concerns have been raised regarding the utility of the test to accurately and precisely detect viral activity early enough to reduce the morbidity and mortality associated with CMV.…”
    Get full text
    Article
  14. 34

    Low Seroconversion after One Dose of AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine in Solid-Organ Transplant Recipients by Mariangela R Resende, Shahid Husain, Jonathan Gubbay, Lianne Singer, Edward Cole, Eberhard L Renner, Coleman Rotstein

    Published 2013-01-01
    “…As a result, solid-organ transplant (SOT) recipients were targeted as a priority group to receive AS03-adjuvanted H1N1 influenza vaccine during 2009.…”
    Get full text
    Article
  15. 35
  16. 36

    Exploring the attitudes of solid organ transplant recipients towards COVID-19 shielding communications and the language of ‘clinically extremely vulnerable’: a qualitative study investigating lessons for the future by Jason Ali, Dominic Summers, Abbie E Greig, Kirsten L Rennie

    Published 2024-04-01
    “…Introduction Solid organ transplant (SOT) recipients were among the first individuals in the UK identified as ‘clinically extremely vulnerable’ (CEV) to COVID-19 and asked to ‘shield’ at the beginning of the pandemic in March 2020. …”
    Get full text
    Article
  17. 37
  18. 38
  19. 39
  20. 40